department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Enbrel · pharmadog

pharmadog
drugs
Enbrel

drug

patient view →

etanercept

Marketedupdated 2mo ago

by $AMGN AMGEN INC

Approved

annual revenue · 2024–2024peak $3.8B

community read0 votes

indications

investigational

Rheumatoid Arthritis

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Enbrel

generic

etanercept

indication

Plaque Psoriasis (Psoriasis Vulgaris)

phase

marketed

approved

1998-11-02

Data sources

openFDA · ClinicalTrials.gov

last refreshed 49m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 3

tagApproval384 co-mentions · 98 sources
drugETICOVO8 co-mentions · 4 sources
companySamsung Bioepis Co Ltd4 co-mentions · 4 sources

Trials studying etanercept

phase3A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasisactive not recruitingn=135
phase3A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participantsactive not recruitingn=120
phase3Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Studycompletedn=34
phase1Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCterminatedn=212
phase1A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune Disorderscompletedn=141
phase3A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritisrecruitingn=458
phase1A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participantscompletedn=48
phase3A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDscompletedn=509

more trials →